ArticleOncoTargets and therapy2019

Durable Molecular Remission in a Lymphoid BP-CML Patient Harboring T315I Mutation Treated with Anti-CD19 CAR-T Therapy.

Lu Zhou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.